A Study of Cusatuzumab Plus Azacitidine in Participants With Newly Diagnosed Acute Myeloid Leukemia Who Are Not Candidates for Intensive Chemotherapy
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Clayton Smith, MD
OncoVerity, Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
56 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- St Vincents Hospital Sydney
Darlinghurst, Australia
- St Vincents Hospital Melbourne
Fitzroy, Australia
- the Alfred Hospital
Melbourne, Australia
- Royal Perth Hospital
Perth, Australia
- Westmead Hospital
Westmead, Australia
- Universidade Estadual de Campinas
Campinas, Brazil
- Hospital Das Clinicas de Porto Alegre
Porto Alegre, Brazil
- Chu D'Angers
Angers, France
- Chu Grenoble
Grenoble, France
- Institut Paoli Calmettes
Marseille, France
- Centre Hospitalier Universitaire (chu) de Bordeaux Hopital Hautleveque Centre Francois Magendie
Pessac, France
- Chu Lyon Sud
Pierre-Bénite, France
- Institut Universitaire Du Cancer Toulouse Oncopole
Toulouse, France
- Chru Tours Hôpital Bretonneau
Tours, France
- Rambam Medical Center
Haifa, Israel
- Hadassah Medical Center
Jerusalem, Israel
- Tel Aviv Sourasky Medical Center
Tel Aviv, Israel
- Azienda Opedaliero-Universitaria Policlinico Sant'Orsola Malpighi Di Bologna
Bologna, Italy
- Azienda Ospedaliera Spedali Civili Di Brescia
Brescia, Italy
- Istituto Scientifico Romagnolo Per Lo Studio E la Cura Dei Tumori
Meldola, Italy
- Asst Grande Ospedale Metropolitano Niguarda
Milan, Italy
- Istituto Europeo Di Oncologia
Milan, Italy
- Division of Hematology, Cardarelli Hospital
Naples, Italy
- Azienda Sanitaria Universitaria Integrata Di Udine
Udine, Italy
- Chelyabinck Regional Clinical Hospital
Chelyabinsk, Russia
- City Clinical Hospital # 40
Moscow, Russia
- S.P. Botkin Moscow City Clinical Hospital
Moscow, Russia
- Nizhniy Novgorod Region Clinical Hospital
Nizhny Novgorod, Russia
- Ryazan Regional Clinical Hospital
Ryazan, Russia
- City Clinical Hospital #15
Saint Petersburg, Russia
- St.-Petersburg Clinical Research Institute of Hematology and Transfusiology
Saint Petersburg, Russia
- Samara Region Clinical Hospital
Samara, Russia
- Oncologic Dispensary No.2
Sochi, Russia
- Komi Republic Oncology Dispensary
Syktyvkar, Russia
- Ekaterinburg City Clinical Hospital # 7
Yekaterinburg, Russia
- Hosp. Quiron Madrid Pozuelo
Pozuelo de Alarcón, Madrid, Spain
- Hosp. Univ. Vall D Hebron
Barcelona, Spain
- Hosp. de la Santa Creu I Sant Pau
Barcelona, Spain
- Inst. Cat. Doncologia-H Duran I Reynals
Barcelona, Spain
- Hosp. Reina Sofia
Córdoba, Spain
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 29 Jul 2019
- Primary completion
- 15 Aug 2023
- Completion
- 15 May 2026
- Last update posted
- 20 Aug 2025
- Registered enrollment
- 103
- Registry id
- NCT04023526
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.